Antiviral T-Cells for Adenovirus in the Pre-Transplant Period: a Bridge Therapy for Severe Combined Immunodeficiency
• Virus specific T-cell therapy was safely utilized in a patient with severe combined immunodeficiency in the pre-transplant period without graft versus host disease.• VST infusion followed by transplant was associated with clearance of disseminated adenovirus.• VST infusion may be an effective…See it on Scoop.it, via Viruses, Immunology & Bioinformatics from Virology.uvic.ca
Antiviral T-Cells for Adenovirus in the Pre-Transplant Period: a Bridge Therapy for Severe Combined Immunodeficiency
Source: Viral Bioinformatics
